These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20633179)

  • 1. Botulinum toxin assessment, intervention and aftercare for lower limb disorders of movement and muscle tone in adults: international consensus statement.
    Olver J; Esquenazi A; Fung VS; Singer BJ; Ward AB;
    Eur J Neurol; 2010 Aug; 17 Suppl 2():57-73. PubMed ID: 20633179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin assessment, intervention and after-care for upper limb hypertonicity in adults: international consensus statement.
    Sheean G; Lannin NA; Turner-Stokes L; Rawicki B; Snow BJ;
    Eur J Neurol; 2010 Aug; 17 Suppl 2():74-93. PubMed ID: 20633180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin assessment, intervention and after-care for lower limb spasticity in children with cerebral palsy: international consensus statement.
    Love SC; Novak I; Kentish M; Desloovere K; Heinen F; Molenaers G; O'Flaherty S; Graham HK;
    Eur J Neurol; 2010 Aug; 17 Suppl 2():9-37. PubMed ID: 20633177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias.
    Rosales RL; Ng AR; Santos MM; Fernandez HH
    Int J Neurosci; 2011; 121 Suppl 1():44-56. PubMed ID: 21348790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum neurotoxin a therapy efficacy and safety for oromandibular dystonia: a meta-analysis.
    Dadgardoust PD; Rosales RL; Asuncion RM; Dressler D
    J Neural Transm (Vienna); 2019 Feb; 126(2):141-148. PubMed ID: 30604200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International consensus statement for the use of botulinum toxin treatment in adults and children with neurological impairments--introduction.
    Esquenazi A; Novak I; Sheean G; Singer BJ; Ward AB
    Eur J Neurol; 2010 Aug; 17 Suppl 2():1-8. PubMed ID: 20633176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin assessment, intervention and aftercare for cervical dystonia and other causes of hypertonia of the neck: international consensus statement.
    Novak I; Campbell L; Boyce M; Fung VS;
    Eur J Neurol; 2010 Aug; 17 Suppl 2():94-108. PubMed ID: 20633181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin assessment, intervention and follow-up for paediatric upper limb hypertonicity: international consensus statement.
    Fehlings D; Novak I; Berweck S; Hoare B; Stott NS; Russo RN;
    Eur J Neurol; 2010 Aug; 17 Suppl 2():38-56. PubMed ID: 20633178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local muscle injection of botulinum toxin type a synergistically improves the beneficial effects of repetitive transcranial magnetic stimulation and intensive occupational therapy in post-stroke patients with spastic upper limb hemiparesis.
    Yamada N; Kakuda W; Kondo T; Mitani S; Shimizu M; Abo M
    Eur Neurol; 2014; 72(5-6):290-8. PubMed ID: 25323412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin assessment, intervention and aftercare for paediatric and adult niche indications including pain: international consensus statement.
    Rawicki B; Sheean G; Fung VS; Goldsmith S; Morgan C; Novak I;
    Eur J Neurol; 2010 Aug; 17 Suppl 2():122-34. PubMed ID: 20633183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin injection into the forearm muscles for wrist and fingers spastic overactivity in adults with chronic stroke: a randomized controlled trial comparing three injection techniques.
    Picelli A; Lobba D; Midiri A; Prandi P; Melotti C; Baldessarelli S; Smania N
    Clin Rehabil; 2014 Mar; 28(3):232-42. PubMed ID: 23945164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.
    Williams SA; Elliott C; Valentine J; Gubbay A; Shipman P; Reid S
    Disabil Rehabil; 2013 Apr; 35(7):596-605. PubMed ID: 22928803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrical stimulation of antagonist muscles after botulinum toxin type A for post-stroke spastic equinus foot. A randomized single-blind pilot study.
    Baricich A; Picelli A; Carda S; Smania N; Cisari C; Santamato A; de Sire A; Invernizzi M
    Ann Phys Rehabil Med; 2019 Jul; 62(4):214-219. PubMed ID: 31228593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy.
    Wasiak J; Hoare B; Wallen M
    Cochrane Database Syst Rev; 2004 Oct; (4):CD003469. PubMed ID: 15495055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin type-A treatment in spastic paraparesis: a neurophysiological study.
    Pauri F; Boffa L; Cassetta E; Pasqualetti P; Rossini PM
    J Neurol Sci; 2000 Dec; 181(1-2):89-97. PubMed ID: 11099717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of focal dystonia involving multiple muscles with a single injection of botulinum toxin A to 1 muscle: A case report.
    Lee SY; Lee HD; Cho YS; Han SH
    Medicine (Baltimore); 2018 Oct; 97(42):e12785. PubMed ID: 30334967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Goal attainment following upper-limb botulinum toxin-A injections: are we facilitating achievement of client-centred goals?
    Nott MT; Barden HL; Baguley IJ
    J Rehabil Med; 2014 Oct; 46(9):864-8. PubMed ID: 25074437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part I): muscle afferent block versus botulinum toxin-A in cervical and limb dystonias.
    Rosales RL; Santos MM; Ng AR; Teleg R; Dantes M; Lee LV; Fernandez HH
    Int J Neurosci; 2011; 121 Suppl 1():35-43. PubMed ID: 21244305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Simpson DM; Blitzer A; Brashear A; Comella C; Dubinsky R; Hallett M; Jankovic J; Karp B; Ludlow CL; Miyasaki JM; Naumann M; So Y;
    Neurology; 2008 May; 70(19):1699-706. PubMed ID: 18458230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.